Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Wiel, B.A. van de"'
Autor:
Versluis, J.M., Reijers, I.L.M., Rozeman, E.A., Menzies, A.M., Akkooi, A.C.J. van, Wouters, M.W., Ch'ng, S., Saw, R.P.M., Scolyer, R.A., Wiel, B.A. van de, Schilling, B., Long, G.V., Blank, C.U.
Publikováno v:
European Journal of Cancer, 148, 51-57. ELSEVIER SCI LTD
Background: Patients with synchronous clinical stage III melanoma can present with primary melanoma lesions, locally recurrent melanoma or in-transit metastases. Neoad-juvant ipilimumab plus nivolumab induces high pathologic response rates and an imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1fde8b660487a3300247bf460369d7bd
https://hdl.handle.net/1887/3276135
https://hdl.handle.net/1887/3276135
Autor:
Rozeman, E.A., Hoefsmit, E.P., Reijers, I.L.M., Saw, R.P.M., Versluis, J.M., Krijgsman, O., Dimitriadis, P., Sikorska, K., Wiel, B.A. van de, Eriksson, H., Gonzalez, M., Acosta, A.T., Grijpink-Ongering, L.G., Shannon, K., Haanen, J.B.A.G., Stretch, J., Ch'ng, S., Nieweg, O.E., Mallo, H.A., Adriaansz, S., Kerkhoven, R.M., Cornelissen, S., Broeks, A., Klop, W.M.C., Zuur, C.L., Houdt, W.J. van, Peeper, D.S., Spillane, A.J., Akkooi, A.C.J. van, Scolyer, R.A., Schumacher, T.N.M., Menzies, A.M., Long, G.V., Blank, C.U.
Publikováno v:
Nature medicine. 27(2)
Neoadjuvant ipilimumab plus nivolumab showed high pathologic response rates (pRRs) in patients with macroscopic stage III melanoma in the phase 1b OpACIN () and phase 2 OpACIN-neo () studies(1,2). While the results are promising, data on the durabili
Autor:
Rozeman, E.A., Prevoo, W., Meier, M.A.J., Sikorska, K., Wiel, B.A. van de, Broeks, A., Tinteren, H. van, Kapiteijn, E., Thienen, J.V., Haanen, J.B., Blank, C.U.
Publikováno v:
Annals of Oncology, 28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::73cc3eb7a2ec0e776d8b78fe2e7b9cb2
https://hdl.handle.net/1887/96176
https://hdl.handle.net/1887/96176